Skip to main content
Fig. 7 | Diagnostic Pathology

Fig. 7

From: The multi-omics analyses of acsl1 reveal its translational significance as a tumor microenvironmental and prognostic biomarker in clear cell renal cell carcinoma

Fig. 7

Drug sensitivities prediction based on ACSL1 expression in ccRCC. (A) The predicted IC50 values for ACSL1 high- and low-expression groups in ccRCC to Temsirolimus and Pictilisib treatment. (B) The predicted IC50 values for ACSL1 high- and low-expression groups in ccRCC to Pazopanib and Sorafenib treatment. *P < 0.05, **P < 0.01, ***P < 0.001

Back to article page

Diagnostic Pathology

ISSN: 1746-1596

Contact us